Patents Assigned to BIOADATP, LLC
  • Enkephalin-influencing composition and method
    Patent number: 10413523
    Abstract: A composition which includes Phenylalanine, Serine, Glutamine and GABA (?-aminobutyric acid). The composition contains the essential amino acids Phenylalanine; Glutamine; the non-essential amino acid Serine; and GABA (?-aminobutyric acid) in concentrations effective to influence or modulate the neurotransmitter pentapeptide enkephalin. The composition may further comprise tetrahydrocannabinol (THC).
    Type: Grant
    Filed: November 16, 2017
    Date of Patent: September 17, 2019
    Assignee: BIOADATP, LLC
    Inventor: Kevin Meehan
  • Enkephalin-influencing composition and method
    Patent number: 9937146
    Abstract: A composition which includes Phenylalanine, Serine, Glutamine and GABA (?-aminobutyric acid). The composition contains the essential amino acids Phenylalanine; Glutamine; the non-essential amino acid Serine; and GABA (?-aminobutyric acid) in concentrations effective to influence or modulate the neurotransmitter pentapeptide enkephalin. The composition may further comprise tetrahydrocannabinol (THC).
    Type: Grant
    Filed: March 23, 2016
    Date of Patent: April 10, 2018
    Assignee: BIOADATP, LLC
    Inventor: Kevin Meehan
  • Composition for enhancing athletic performance
    Patent number: 9271983
    Abstract: A composition including a plurality of active ingredients. A first active ingredient of the active ingredients is pyruvate. For each other active ingredient, an amount of that active ingredient is proportionally less than an amount of the first active ingredient. The composition can affect ATP and Krebs efficiency when ingested by an animal.
    Type: Grant
    Filed: December 18, 2012
    Date of Patent: March 1, 2016
    Assignee: BIOADATP, LLC
    Inventor: Kevin Meehan